XML 15 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Mar. 25, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --12-31    
Entity File Number 001-37428    
Entity Registrant Name Qualigen Therapeutics, Inc.    
Entity Central Index Key 0001460702    
Entity Tax Identification Number 26-3474527    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 5857 Owens Avenue    
Entity Address, Address Line Two Suite 300    
Entity Address, City or Town Carlsbad    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92008    
City Area Code (760)    
Local Phone Number 452-8111    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol QLGN    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 4,570,535
Entity Common Stock, Shares Outstanding   6,307,371  
Documents Incorporated by Reference [Text Block] None.    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 23    
Auditor Name Baker Tilly US, LLP    
Auditor Location San Diego, California